NCT03936816 is a clinical trial of GBS vaginal double swab in GBS, sponsored by Carmel Medical Center.

Who is sponsoring NCT03936816?

NCT03936816 is sponsored by Carmel Medical Center.

What drugs are being tested in NCT03936816?

Interventions in NCT03936816: GBS vaginal double swab.

Is NCT03936816 still recruiting?

NCT03936816 is currently completed. Last updated 23 September 2020.

Last reviewed 2020-09-23 · How we verify

NCT03936816

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis

Completed Last updated 23 September 2020

What this trial tests

trial testing GBS vaginal double swab in GBS in 303 participants. Completed in 30 August 2020.

Timeline

1 June 2019

Primary endpoint
15 August 2020

30 August 2020

Quick facts

Lead sponsor	Carmel Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	303
Start date	1 June 2019
Primary completion	15 August 2020
Estimated completion	30 August 2020
Sites	1 location across Israel

Drugs / interventions tested

GBS vaginal double swab

Conditions studied

GBS — all drugs for GBS →

Sponsor

Carmel Medical Center

Who can join

Adults 18 to 45, female only, with GBS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The implementation of real-time PCR for detection of intrapartum GBS (group B Streptococcus) colonization as a way to reduce antibiotic prophylaxis usage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for GBS

Currently open trials in the same condition.

NCT04871035 — Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS) · recruiting

Other Carmel Medical Center trials

Trials by the same sponsor.

NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
NCT06612749 — Assessing the Impact of Integrative Medicine on Anxiety and Wellbeing of Healthcare Providers Exposed to Terror or War · NA · recruiting
NCT06598020 — Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers · NA · active not recruiting
NCT06590766 — Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum · NA · recruiting
NCT06167057 — POST URS Chemotherapy Instillation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03936816 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carmel Medical Center
Last refreshed: 23 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03936816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing